Cell Therapy Archives | Page 13 of 62

Vector BioMed Expands LENTIVERSE™ Platform and Unveils New Brand Identity to Close the Gap Between CGT Innovation and Patient Access

November 14, 2025 By BioInformant Team Leave a Comment

The expansion of LENTIVERSE™ platform introduces “One Lentiviral Vector Platform, Two Paths to Advance Cures,” aligning scientific rigor with transparent economics and global accessibility.

GAITHERSBURG, Md., Nov. 6, 2025 — Vector BioMed, a leading lentiviral vector supplier and contract vector development and manufacturing organization (CVDMO), today announced the expansion of its LENTIVERSE™ platform alongside the unveiling of its new brand identity, designed to accelerate global gene therapy access by providing custom and ready-to-deploy solutions. This expansion strengthens the company’s mission to make gene therapies more accessible and cost-effective for patients worldwide. [Read more…]

Bridging the Gap: Streamlining iPSC-Derived Cell Line Development from Donor Cells to MCB

November 14, 2025 By BioInformant Team Leave a Comment

Allogeneic iPSC-derived therapies hold immense promise, offering scalable, off-the-shelf solutions for a wide spectrum of diseases. However, the journey from donor cells to a gene edited, clinically compliant GMP Master Cell Bank (MCB) is fraught with challenges and is particularly vulnerable to risks stemming from misaligned early development.

A major bottleneck seen in the majority of iPSC therapeutic programs arises when development teams continue to rely on R&D grade cell lines to confirm proof-of-concept, conduct preclinical animal studies, and to start process & analytical development. [Read more…]

What is CAR-T Cell Therapy? A New Way to Treat Cancer

November 3, 2025 By Cade Hildreth, Founder & President 1 Comment

CAR-T cell therapy is as a type of immunotherapy that teaches T cells to recognize and destroy cancer. CAR-T cell therapy has demonstrated promising results in a range of patients across the globe. In some patients, this can lead to the total elimination of the cancer. In others, there is a significant improvement of the disease.

For those confronting cancer, one crucial question often arises: What is CAR-T cell therapy? This guide answers the most common questions and explains how this innovative technology is transforming the future of cancer treatment.

[Read more…]

What is the Definition of Regenerative Medicine (RM)?

November 2, 2025 By Cade Hildreth, Founder & President Leave a Comment

As with any rapidly evolving field, defining the scope and boundaries of regenerative medicine is a challenge. However, understanding this innovative industry requires examining the foundational components of the human body and the groundbreaking technologies designed to restore or enhance its function. To understand the definition of this scientific field, it is critical to understand the key components that compose the human body, which are: [Read more…]

List of U.S. FDA Approved Cell and Gene Therapy Products (46)

November 2, 2025 By Cade Hildreth, Founder & President 2 Comments

Today, researchers and clinicians are under great pressure to develop therapies capable of reversing or significantly impacting the progression of disease. In recent years, the arrival of the cell and gene therapy industries have introduced the possibility of providing transformative, durable and potentially curative outcomes for a diverse range of life-threatening conditions, as well as injuries, degenerative diseases, genetic disorders, and cancers. [Read more…]